Walleye Capital
ABMD

Walleye Capital’s Abiomed Inc ABMD Stock Holding History

Walleye Capital’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,500
Closed -$368K – 3879
2022
Q3 		$368K Buy
+1,500
New +$405K 0.01% 1677
2020
Q1 		– Sell
-7,200
Closed -$1.23M – 1900
2019
Q4 		$1.23M Sell
7,200
-8,900
-55% -$1.65M 0.08% 346
2019
Q3 		$2.86M Buy
16,100
+14,500
+906% +$3.13M 0.17% 137
2019
Q2 		$417K Buy
1,600
+1,100
+220% +$292K 0.05% 575
2019
Q1 		$143K Buy
+500
New +$166K 0.02% 906

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Walleye Capital's ABMD Position: Q4 2022 in Review

Walleye Capital sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 1,254 shares — an estimated $308K sold.

Walleye Capital first reported a position in ABMD in Q1 2019 and held it in 6 quarters. The position peaked at $2M in Q3 2019. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Walleye Capital reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Walleye Capital sold 1,254 Abiomed Inc shares in Q4 2022, an estimated $308K.
  • Walleye Capital first reported a position in Abiomed Inc in Q1 2019 and held it in 6 quarters.
  • Walleye Capital's Abiomed Inc position peaked at $2M in Q3 2019.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Walleye Capital's 13F filing for Q4 2022, filed 14 Feb 2023.